State Board of Veterinary Medicine: News
- Permanent Rulemaking Hearing - October 10, 2019
- Stakeholder Meeting - September 24, 2019
- Joint Stakeholder Meeting - August 19, 2019
- Listen to PDMP Townhall; new document answers FAQs
- New Legislation 2019
- Annual Ethics Training
- Revised Opioid Guidelines Endorsed
- Board Adopts New Policy Regarding the Use of Telehealth
- New Law Affects Colorado Prescribers, Limits Opioid Prescriptions
- General Opioid Guidelines
- Updated Veterinary Opioid Prescribing and Dispensing Policy
- PDMP Delegate Training Video
- Changes to Disciplinary Procedures
- Mandatory Reporting Reminder
- Important PDMP Updates
The State Board of Veterinarian Medicine held a Permanent Rulemaking Hearing to consider adopting the proposed amendments to Rule 1.2 (formerly Rule 2). The changes to this rule are being considered to implement new legislation, Senate Bill 19-228.
- A copy of proposed rule changes and Senate Bill 19-228 is available for download.
- Thursday, October 10, 2019 at 9:00 A.M. (MDT)
Listen to the hearing held October 10, 2019
The State Board of Veterinary Medicine held a stakeholder meeting to receive input on the proposed changes to rule 1.2, to implement Senate Bill 19-228 (SB19-228). This new legislation requires veterinarians to complete up to four (4) hours of substance use disorder training as a condition of renewal, reactivation, or reinstatement of licensure.
- A copy of the proposed rule changes and SB19-228 is available for download.
- Tuesday, September 24, 2019, from 9:00 A.M. – 10:00 A.M. (MDT)
Listen to the Meeting
The Colorado Podiatry Board, State Board of Optometry, State Board of Veterinary Medicine, Colorado Dental Board, Colorado Medical Board, and Board of Nursing will hold a Joint Stakeholder Meeting to receive input regarding the implementation of Colorado Senate Bill 19-228 (SB19-228), as it relates to a requirement that physicians, physician assistants, podiatrists, dentists, advanced practice nurses with prescriptive authority, optometrists, and veterinarians complete substance use disorder training in order to renew, reactivate, or reinstate a license.
- A copy of the SB19-228 and a list of questions that the Division requests specific feedback on, to help aid the Boards in adopting rules to implement this legislation is available for download.
- Monday, August 19, 2019, 12:30 p.m. (MDT)
Three Ways to Participate
- In Person: Civic Center Plaza, 1560 Broadway, Room 100C (1st Floor), Denver, CO 80202
- By Webinar: Register Here
- Submit Comments: Oral comments will be taken from participants who are present in-person or participating via webinar. If you cannot make the meeting in-person or wish to make written comments rather than speaking, you may email your written comments to: firstname.lastname@example.org on or before Friday, August 16, 2019.
Stakeholder input will be limited to discussions on the implementation of SB19-228. The Boards need your help to identify how these changes might affect consumer outcomes, positive or negative, and to assess “how” and “what” changes should be considered to implement the new legislation. Written and oral comments will be available for the Boards to consider prior to beginning the formal rulemaking process. If you have any questions or concerns about stakeholder input, please send them to email@example.com.
The Division of Professions and Occupations hosted a Veterinary Telephone Townhall on July 25, 2019, that addressed Colorado's requirements for prescribers related to the Prescription Drug Monitoring Program.
Among the topics covered were the unique Veterinary Policy for Prescribing and Dispensing Opioids, and potential reservations and pitfalls faced by vets who are or aren't, using the PDMP. A three-person panel comprised of Drs. Lee Newman, Stacey Meola, and Ragan Adams led an informative discussion. The panel has experience in rural and urban settings, with small and large animal populations, and within the academic community, and examined issues related to controlled substance prescribing for veterinarians.
The Townhall recording is available below for those licensees who were unable to participate in this session. A Q-and-A document also can be accessed that answers many frequently asked questions about the PDMP, its use, benefits, and contact information related to its operation.
On May 23, 2019, Governor Jared Polis signed SB19-228 Substance Use Disorders Prevention. The law went into effect immediately upon the Governor’s signature. The law requires the Colorado Medical Board, State Board of Nursing, Colorado Dental Board, State Board of Optometry, Colorado Podiatry Board, and the State Board of Veterinary Medicine to adopt rules on substance use disorder training for prescribers. The rules must require certain health care providers, as a condition of license renewal, reactivation or reinstatement on or after October 1, 2019, to complete up to four credit hours of training per licensing cycle related to:
- Best practices for opioid prescribing, according to the most recent version of the Division’s Guidelines for Prescribing and Dispensing Opioids;
- Recognition of substance use disorders;
- Referral of patients with substance use disorders for treatment; and,
- Use of the Electronic Prescription Drug Monitoring Program.
The new requirements apply to podiatrists, physicians, physician assistants, dentists, advanced practice nurses with prescriptive authority, optometrists, and veterinarians, except that each Board’s rules must exempt from the training requirements any health care provider who:
- Maintains a national board certification that requires equivalent substance use prevention training; or
- Attests to the appropriate board that the health care provider does not prescribe opioids.
In addition to the substance abuse prevention training requirements, the new law includes the following provisions:
- Restricts a physician, physician assistant, or advanced practice nurse from accepting any direct or indirect benefits for prescribing a specific medication,
- Allows pharmacies to charge enhanced dispensing fees if they provide counseling concerning the risks of opioids to patients who have not previously received opioid prescriptions,
- Allows medical examiners and coroners to access the Prescription Drug Monitoring Program (PDMP) under specified circumstances,
- Requires opioid prescriptions for outpatient use to bear a warning label, and,
- Provides funding for the implementation of several programs for the prevention of opioid and other substance use disorders in the Department of Human Services (DHS), the Department of Public Health and Environment (CDPHE) and local public health agencies (LPHAs), and the University of Colorado.
On March 14, 2019, the revised Guidelines for Prescribing and Dispensing Opioids were adopted by all six of Colorado’s prescribing and dispensing Boards: the Colorado Dental Board, the Colorado Medical Board, the State Board of Nursing, the State Board of Optometry, the Colorado Podiatry Board, and the State Board of Pharmacy, and endorsed by the State Board of Veterinary Medicine.
Board Guidelines for the Appropriate Use of Telehealth Technologies in the Practice of Veterinary Medicine were adopted on October 18, 2018 to educate licensees as to the appropriate use of telehealth technologies in the delivery of veterinary medicine services directly to a client/patient.
The advancements and continued development of veterinary medicine and communications technology offer opportunities for improving the delivery and accessibility of veterinary care.
These new guidelines DO NOT:
- Set a different standard of care;
- Alter generally accepted standards of practice;
- Change the scope of practice of any licensed veterinarians;
- Permit the delivery of services in a setting, or in a manner not otherwise authorized by law.
We encourage you to review the new guidelines and see how they may provide opportunities for your practice.
Please refer to the Q&A on Veterinary Telehealth for additional information.
The State Board of Veterinary Medicine has reviewed Senate Bill 18-22 Clinical Practice for Opioid Prescribing, and considered its impact on the Guidelines for Prescribing and Dispensing Opioids. The Board on Dec. 20, 2018 endorsed changes made necessary by SB 18-22 relating to the updated guidelines.
Senate Bill 18-22 was signed last May and immediately went into effect upon the Governor’s signature. This new state law limits the number of opioid pills a healthcare provider can prescribe and affects veterinarians, physicians, physician assistants, advanced practice registered nurses with prescriptive authority, dentists, optometrists, and podiatrists.
Under the new law, a prescriber must limit a patient’s initial prescription of an opioid to a seven-day supply, if the prescriber has not written an opioid prescription for the patient in the last 12 months. The prescriber may exercise discretion in including a second fill for a seven-day supply. These limits do not apply, if, in the judgment of the prescriber, the patient:
- Has chronic pain that typically lasts longer than 90 days or past the time of normal healing, as determined by the prescriber, or following transfer of care from another prescriber who prescribed an opioid to the patient;
- Has been diagnosed with cancer and is experiencing cancer related pain; or
- Is experiencing post-surgical pain, that, because of the nature of the procedure, is expected to last more than 14 days.
After the first prescription, the prescriber is required to check the Prescription Drug Monitoring Program (PDMP) database before prescribing any additional opioids for the same patient. Failure to check the PDMP constitutes unprofessional conduct if the prescriber repeatedly fails to comply with this new requirement. The second fill requirement to check the PDMP does not apply when a patient:
- Is receiving the opioid in a hospital, skilled nursing facility, residential facility, or correctional facility;
- Has been diagnosed with cancer and is experiencing cancer related pain; or
- Is undergoing palliative care or hospice care;
- Is experiencing post-surgical pain, that, because of the nature of the procedure, is expected to last more than 14 days;
- Is receiving treatment during a natural disaster or during an incident where mass casualties have taken place; or has received only a single dose to relieve pain for a single test or procedure.
After the second opioid prescription, the law has no further restrictions on the healthcare provider’s prescribing practices. The new law does require a healthcare provider, or the provider’s designee, to specify the provider’s specialty upon the initial query of the PDMP. It also states a violation of the new requirements does not constitute negligence or contributory negligence per se and does not create a private right of action or serve as the basis of a cause of action.
On March 16, 2018, the revised Guidelines for Prescribing and Dispensing Opioids were adopted by all six of Colorado’s prescribing and dispensing Boards: the Colorado Dental Board, the Colorado Medical Board, the State Board of Nursing, the State Board of Optometry, the Colorado Podiatry Board, and the State Board of Pharmacy, and endorsed by the State Board of Veterinary Medicine.
This revised Policy is a product of the collaboration between the seven Boards and a robust stakeholder engagement process. Stakeholder views, opinions and comments were essential in the revision of the 2014 Policy for Prescribing and Dispensing Opioids.
On December 14, 2017, the State Board of Veterinary Medicine updated the veterinary opioid policy for the prescribing and dispensing of opioids to reflect changes from SB 17-146 Access to Prescription Drug Monitoring Program, which was signed into law on April 6, 2017. This policy was adopted in an effort to provide guidelines and to assist prescribing veterinarians. The Board believes that opioid use in a veterinary practice setting requires a unique policy that provides meaningful guidance to veterinarians who treat a wide variety of animals in Colorado. However, Colorado veterinarians may use an alternative approach if the approach satisfies the requirements of the applicable statutes, regulations, and standard of care.
A training video is available to show prescribers and pharmacists how to set up delegate accounts for the PDMP. Any prescriber or pharmacist can create up to three delegate accounts for trained individuals who can check the PDMP on the prescriber or pharmacist's behalf. You can utilize the PDMP more frequently to get the most complete medical history possible.
On June 6, 2017, Governor John Hickenlooper signed House Bill 17-1165 (HB17-1165) Department of Regulatory Agencies Boards Disciplinary Action Resolution Process. The new law became effective upon the Governor’s signature on June 6, 2017, and modifies the disciplinary procedures for six healthcare boards (prescriber boards) within the Division of Professions and Occupations in the Department of Regulatory Agencies (DORA). The prescriber boards affected include:
- Colorado Dental Board;
- Colorado Medical Board;
- State Board of Nursing;
- State Board of Optometry;
- Colorado Podiatry Board; and
- State Board of Veterinary Medicine.
As part of the bill’s implementation, we want to make sure you are aware of certain deadlines that affect the prescriber boards’ complaint processes and how you may need to respond to a board request. The following deadlines now apply unless a prescriber board has more protective provisions in current state law:
- Within 15 days of receipt of a complaint, the boards must provide the complainant with a written notice that includes contact information for the board, a summary of the complaint process and the complainant's rights, including a patient's right to receive a copy of his or her patient records.
- If relevant to a complaint, licensees must provide the board with patient records within 30 days of a board request for the records in the form of the response to a 30-day letter.
- If an investigation was initiated as a result of a complaint, and the board took public, formal action, the board must provide the complainant with written notice of the action within 30 days of the action.
- If a complaint is still pending after six months, the board must notify the complainant that the complaint is still pending, subject to applicable restrictions in state law.
- Each prescriber board is required to update its website within 30 days after suspending or revoking a license, listing each licensee subject to the suspension or revocation separately.
Finally, insurance carriers must now update their participating provider lists every 30 days to remove providers whose licenses have been suspended or revoked.
These deadlines are now in effect as required by state law. If you have questions about the new requirement or any other aspect of House Bill 17-1165, please contact Jo Donlin at firstname.lastname@example.org or 303-894-7434.
Did you know you are a mandatory reporter? Under Colorado law, more than 40 professions are required to report suspected child abuse and elder abuse. These professions include many regulated through the Division of Professions and Occupations (DPO) at DORA, such as:
- Physicians (including physician assistants and physicians in training);
- Dentists and dental hygienists;
- Nurses (including registered nurses, licensed practical nurses, and nurse practitioners);
- Nursing home administrators;
- Occupational therapists;
- Physical therapists;
- Mental health professionals (including psychologists, social workers, professional counselors, marriage and family therapists, registered psychotherapists and all candidates for licensure);
Online trainings help mandatory reporters recognize and report abuse, neglect and exploitation. Licensees of the regulatory boards at DPO may accrue credit towards continuing education and continuing competency requirements for completing the trainings (should they exist for their profession).
Section 19-3-304, C.R.S. outlines the persons required by law to report child abuse and/or neglect. To assist mandatory reporters, a training is available on the Colorado Department of Human Services website at http://coloradocwts.com/mandated-reporter-training.
Section 18-6.5-108, C.R.S outlines the persons required by law to report abuse and exploitation of at-risk elders and at-risk adults with intellectual and developmental disabilities. Further information and an online training can be found on the Colorado Department of Human Services website at http://www.coloradoaps.com/about-mandatory-reporting-update.html.
If you have further questions regarding these requirements, please contact the Colorado Department of Human Services.
For questions regarding mandatory reporting of at-risk elders and at-risk adults with intellectual and developmental disabilities, please contact the Office of Community Access and Independence’s Division of Aging and Adult Services at email@example.com.
As we work together to tackle prescription drug misuse, abuse and diversion, we see PDMP utilization rates continue to increase as the database continues to serve as an important tool for meeting the standard of care for safe prescribing.
We are pleased to announce a new and improved PDMP website: colorado.gov/dora-pdmp. We listened to your challenges and ideas and hope you’ll find the new website easier to navigate and more relevant to your needs. You will be able to link to your PDMP account and access other information directly from the homepage. We also selected a new vendor, APPRISS, and will be utilizing the PMP AWARxE system. The database interface will look different and make PDMP queries easier and quicker. We encourage your continued feedback for ongoing improvement efforts.
New State Law Improves Access to PDMP
To make the PDMP more accessible and easier for health professionals to incorporate into daily use, the Colorado General Assembly passed legislation in 2017. On April 6, 2017, Governor John Hickenlooper signed Senate Bill 17-146 Access To Prescription Drug Monitoring Program, which clarifies health professionals' access to the PDMP database by:
- Allowing a health care provider with prescribing authority to query the PDMP about a current patient, including checking on drug interactions and side effects, thus making the PDMP an even more useful tool for health professionals in their clinical decision-making for patients;
- Allowing a veterinarian with prescribing authority to query the PDMP about a current client if the veterinarian has a reasonable basis to suspect the client has committed drug abuse or has mistreated an animal; and
- Allowing a pharmacist to query the PDMP about a current patient for whom the pharmacist is dispensing any prescription drug, rather than only patients receiving controlled substances.
The law became effective immediately, and the Division is working with the appropriate Boards to implement the new law including rulemaking, outreach and education. If you have questions about the Colorado PDMP, please contact Division staff at 303-894-5957 or firstname.lastname@example.org. If you need technical assistance with the PMP AWARxE system, please contact the vendor help desk at 1-855-263-6403.